<DOC>
	<DOCNO>NCT00474136</DOCNO>
	<brief_summary>The purpose study assess pharmacokinetic parameter intravenous diclofenac sodium ( DIC075V ) 18.75 mg 37.5 mg follow single- multiple-dose administration , compare oral diclofenac potassium ( Cataflam® 50 mg ) , approve reference product .</brief_summary>
	<brief_title>Study Compare Pharmacokinetics IV Diclofenac Sodium ( 2 Doses ) Versus Oral Diclofenac Potassium</brief_title>
	<detailed_description>This study open-label , three-treatment , six sequence , three-period , single center crossover study evaluate pharmacokinetics intravenous diclofenac sodium DIC075V ( 18.75 mg 37.5 mg ) versus oral diclofenac potassium ( Cataflam® 50 mg ) healthy adult volunteer follow single- multiple-dose administration . Each treatment sequence receive 1 dose every 6 hour ( total 4 dos per treatment sequence ) 48-hour washout period treatment sequence .</detailed_description>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Healthy volunteer 18 55 year age . Smoked used tobacco nicotine product past six month expect study . Known allergy hypersensitivity diclofenac , aspirin , NSAIDs . History previous and/or present peptic ulceration , GI bleed bleed diathesis , positive hepatitis B hepatitis C HIV antibody , history asthma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>